# Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions

> **NCT00906087** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 14 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Cosopt (combination eyedrop of dorzolamide and timolol)

## Key facts

- **NCT ID:** NCT00906087
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-04
- **Primary completion:** 2012-07-18
- **Final completion:** 2012-07-18
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00906087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00906087, "Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00906087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
